Raffael Liegl

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE

Dawn A. Sim, Tina Herold, Ricarda G. Schumann et al. · Retina · 2017 · 146 citations · Full text

Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study

Louisa M. Bulirsch, Marlene Saßmannshausen, Jennifer Nadal et al. · British Journal of Ophthalmology · 2021 · 119 citations · Full text

Inflammatory signals from photoreceptor modulate pathological retinal angiogenesis via c-Fos

Ye Sun, Zhiqiang Lin, Chi‐Hsiu Liu et al. · The Journal of Experimental Medicine · 2017 · 80 citations · Full text

Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment

Lukas Reznicek, S. Cserhati, Florian Seidensticker et al. · Acta Ophthalmologica · 2013 · 66 citations · Full text